Tango Therapeutics (TNGX) Retained Earnings (2020 - 2026)
Tango Therapeutics' (TNGX) quarterly Retained Earnings came in at -$115000.0 in Q1 2026, down 159.28% year-on-year from $194000.0 in Q1 2025, and down 100.01% quarter-over-quarter from $949.0 million in Q4 2025.
Tango Therapeutics (TNGX) Retained Earnings (2020 - 2026) Analysis & Trends
Tango Therapeutics' Retained Earnings history runs 7 years deep, the most recent figure standing at -$115000.0 for Q1 2026.
- On a quarterly basis, Retained Earnings fell 159.28% year-over-year to -$115000.0 in Q1 2026; TTM through Mar 2026 was -$115000.0, a 159.28% decrease from a year earlier, with the FY2025 full-year figure at $949.0 million, up 282331.85% from the prior year.
- Retained Earnings fell to -$115000.0 in Q1 2026 per TNGX's latest filing, from $949.0 million in the prior quarter.
- Across five years, Retained Earnings topped out at $949.0 million in Q4 2025 and bottomed at -$269.5 million in Q4 2022.
- The 5-year median for Retained Earnings is $194000.0 (2025), against an average of $187.4 million.
- Across the five-year window, Retained Earnings slumped 2404420.0% in 2022 and jumped 282331.85% in 2025, its largest moves.
- Year by year, Retained Earnings stood at -$269.5 million in 2022, then jumped by 100.07% to $186000.0 in 2023, then jumped by 80.65% to $336000.0 in 2024, then soared by 282331.85% to $949.0 million in 2025, then sank by 100.01% to -$115000.0 in 2026.
- Per Business Quant, the three latest TNGX Retained Earnings figures stand at -$115000.0 (Q1 2026), $949.0 million (Q4 2025), and $121000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Tango Therapeutics | 3.94 Bn | 3.78 Bn | - | -115,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -115,000.00 |
| Dec 31, 2025 | 948.97 Mn |
| Sep 30, 2025 | 121,000.00 |
| Jun 30, 2025 | 715.04 Mn |
| Mar 31, 2025 | 194,000.00 |
| Dec 31, 2024 | 336,000.00 |
| Sep 30, 2024 | 750,000.00 |
| Jun 30, 2024 | -334,000.00 |
| Mar 31, 2024 | 673.77 Mn |
| Dec 31, 2023 | 186,000.00 |
| Sep 30, 2023 | -681,000.00 |
| Jun 30, 2023 | 532.60 Mn |
| Mar 31, 2023 | 526.90 Mn |
| Dec 31, 2022 | -269.51 Mn |
| Sep 30, 2022 | -240.45 Mn |
| Jun 30, 2022 | -211.40 Mn |
| Mar 31, 2022 | 510.22 Mn |
| Dec 31, 2021 | -161.34 Mn |
| Sep 30, 2021 | -10,000.00 |
| Jun 30, 2021 | -1.13 Mn |